Have specific questions?

Talk with Expert

Meghann Howland

Vice President Therapeutic Strategy
Oncology, Rare Disease and Inflammatory Medicine
Over 25 Years' Experience

Meet All Worldwide's Experts

Meghann Howland, Vice President Therapeutic Strategy – Oncology, Rare Disease and Inflammatory Medicine

Over 20 years of clinical and drug development expertise, with a focus on early phase oncology, immunology and rare disease. Over 25 years of experience across multiple other therapeutics.